Are μ-opioid receptor polymorphisms important for clinical opioid therapy?

This publication has 68 references indexed in Scilit:

• Effect of the A118G polymorphism on binding affinity, potency and agonist‐mediated endocytosis, desensitization, and resensitization of the human mu‐opioid receptor
  Journal of Neurochemistry, 2004
• Pharmacokinetic-Pharmacodynamic Modeling of Morphine-6-glucuronide-induced Analgesia in Healthy Volunteers
  Anesthesiology, 2004
• Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin
  Human Mutation, 2002
• Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes
  Published by Elsevier ,2000
• Association analysis of polymorphisms in the mu opioid gene and heroin abuse in Chinese subjects
  Addiction Biology, 2000
• Association of a functional ?-opioid receptor allele (+118A) with alcohol dependency
  American Journal of Medical Genetics, 1999
• μ opioid receptor gene variants: lack of association with alcohol dependence
  Molecular Psychiatry, 1997
• Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse
  Addiction Biology, 1997
• The pharmacogenetics of codeine hypoalgesia
  Pharmacogenetics, 1995
• Antisense mapping the MOR‐1 opioid receptor: evidence for alternative splicing and a novel morphine‐6β‐glucuronide receptor
  FEBS Letters, 1995